ClinicalTrials.Veeva

Menu

Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial (EPICS)

M

Morehouse School of Medicine

Status

Unknown

Conditions

Colorectal Cancer

Treatments

Behavioral: Active Arm #1, #2, Passive Arm #1, #2

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01805622
1R01CA166785 (U.S. NIH Grant/Contract)
EPICS cRCT

Details and patient eligibility

About

  • Hypothesis 1. When compared to passive dissemination, active dissemination will result in greater participant enrollment.
  • Hypothesis 2. The intervention will be offered with equal fidelity in churches, clinics and community sites.
  • Hypothesis 3. Knowledge of CRC screening and perceived risk of CRC will be positively correlated.

Full description

In this study, investigators aim to evaluate 20 community coalitions and 7,200 participants by: testing passive and active approaches to disseminating the Educational Program to Increase Colorectal Cancer Screening (EPICS) to increase screening rates for colorectal cancer; measuring the extent to which EPICS is accepted and the fidelity of implementation in various settings and estimating the potential translatability and public health impact of EPICS. This four-arm cluster randomized trial (five community coalitions plus 1,800 African Americans, 50-74 years of age, who are not current on colorectal cancer (CRC) screening per arm) compares the following implementation strategies: (1) web access to facilitator training materials and toolkits without technical assistance (TA); (2) web access, but with technical assistance (TA); (3) in-person access to facilitator training materials and toolkits without TA and (4) in-person access with TA. Primary outcome measures are the reach (the proportion of representative eligible community coalitions and individuals participating in the trial) and effectiveness (post-intervention changes in CRC screening rates). Secondary outcomes include adoption (percentage of community coalitions implementing the EPICS sessions) and implementation (quality and consistency of the intervention delivery). The extent to which community coalitions continue to implement EPICS post-implementation (maintenance) will also be measured. Cost-effectiveness analysis will be conducted to compare passive to active dissemination costs. Investigators believe that implementing this evidence-based colorectal cancer screening intervention in partnership with community coalitions will result in more rapid adoption than traditional top-down approaches, and that changes in community CRC screening practices are more likely to be sustainable over time. With its national reach, this study has the potential to enhance understanding of barriers and enablers to the uptake of educational programs aimed at eliminating cancer health disparities.

Enrollment

7,200 estimated patients

Sex

All

Ages

50 to 74 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • African Americans, 50-74 years of age, who are not current on CRC screening, are eligible for study participation

Exclusion criteria

  • Individuals with a personal history of CRC or inflammatory bowel disease, blindness or severe hearing impairment; dementia; or other condition with life expectancy less than two years, are ineligible for participation

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7,200 participants in 4 patient groups

Passive Arm #1
Experimental group
Description:
Active Arm #1, 2; Passive Arm #1, 2 Community coalitions randomized to the Passive Arm #1-Web Access Without Technical Assistance will receive access to EPICS facilitator training materials and toolkits via the Research-Tested Intervention Programs (RTIPs) website and will not participate in monthly technical assistance teleconferences.
Treatment:
Behavioral: Active Arm #1, #2, Passive Arm #1, #2
Passive Arm #2
Experimental group
Description:
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to the Passive Arm #2-Web Access With Technical Assistance will receive access to EPICS facilitator training materials and toolkits via the Research-Tested Intervention Programs (RTIPs) website and will participate in monthly technical assistance teleconferences.
Treatment:
Behavioral: Active Arm #1, #2, Passive Arm #1, #2
Active Arm #1
Active Comparator group
Description:
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to Active Arm #1-In-Person Access Without Technical Assistance will receive training from intervention developers with access to facilitator training materials but will not participate in monthly technical assistance teleconferences.
Treatment:
Behavioral: Active Arm #1, #2, Passive Arm #1, #2
Active Arm #2
Active Comparator group
Description:
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to Active Arm #2-In-Person Access with Technical Assistance will receive training from intervention developers with access to facilitator training materials and will participate in monthly technical assistance teleconferences.
Treatment:
Behavioral: Active Arm #1, #2, Passive Arm #1, #2

Trial contacts and locations

1

Loading...

Central trial contact

Selina A. Smith, PhD, MDiv; Daniel S. Blumenthal, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems